More people entered the labor force, and not all were able to find jobs right away. Bad weather may have been a factor
Consumers like curation—stories that narrow the choices down to the best two or three
With yet another tweak to the health-care law, the Obama administration is heading off a popular Republican attack
Music executives are tapping services such as Shazam and Spotify to help predict tomorrow’s next big hits
In the five years since the most recent bottom, the stock market has very nearly tripled
Arunachalam Muruganantham, aka "Menstrual Man," designed simple devices that allow rural Indian women to make their own sanitary pads
The company's dubbing of storms with Greek and Latin names began in 2012 to help 'personalize' extreme weather
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Organizations offer special training for senior entrepreneurs
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."